Tressler Nick B. reported VTGN

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001794362-25-000005

Machine-readable

Structured copy

Timestamps

Event (reported)

Dec 1, 2025

Published

Dec 4, 2025

Ingested by INSIDER

Nov 5, 04:29 UTC

Last re-read

Nov 5, 04:29 UTC

Extracted facts

Filer

Tressler Nick B.

Role

Chief Financial Officer

Transaction

Grant or awardAs filed: “A”

Asset

Vistagen Therapeutics, Inc. — Common Stock (Right to Buy)

Ticker

VTGN

Shares

150.0K

Execution date (reported)

Dec 1, 2025

Owned after transaction

150.0K shares

Days from execution to publication

3

What this establishes

Tressler Nick B. filed this Form 4 reporting a grant or award of VTGN on Dec 1, 2025. It became public on Dec 4, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Financial Officer

Tressler Nick B.cik:0001794362

Issuer

Vistagen Therapeutics, Inc.cik:0001411685

Revision history · 0

No field has changed since this record was first ingested.